Onivyde I.V. infusion 43 mg General Drug Use-Results Survey (Unresectable pancreatic cancer after disease progression following cancer chemotherapy)
Not Applicable
- Conditions
- Pancreatic cancer
- Registration Number
- JPRN-UMIN000041015
- Lead Sponsor
- IHON SERVIER CO., LTD.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 326
Inclusion Criteria
Not provided
Exclusion Criteria
No given consent to participation in the survey.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Overall incidence of each ADRs and AEs (Safety Specifications of the Survey related)
- Secondary Outcome Measures
Name Time Method